Torthaí cuardaigh - Bob Wilffert

Beachtaigh na torthaí
  1. 1
    Pharmacogenetics of isoniazid-induced hepatotoxicity

    Pharmacogenetics of isoniazid-induced hepatotoxicity de réir Dyah Aryani Perwitasari, Jarir At Thobari, Bob Wilffert

    Foilsithe / Cruthaithe 2014
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  2. 2
    The use of ketamine to cope with depression and post-traumatic stress disorder: A qualitative analysis of the discourses posted on a popular online forum

    The use of ketamine to cope with depression and post-traumatic stress disorder: A qualitative analysis of the discourses posted on a popular online forum de réir Tharcila V. Chaves, Bob Wilffert, Zila M. Sanchez

    Foilsithe / Cruthaithe 2020
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  3. 3
    Overdoses and deaths related to the use of ketamine and its analogues: a systematic review

    Overdoses and deaths related to the use of ketamine and its analogues: a systematic review de réir Tharcila V. Chaves, Bob Wilffert, Zila M. Sanchez

    Foilsithe / Cruthaithe 2022
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  4. 4
    Pharmacogenetics of drug–drug interaction and drug–drug–gene interaction: a systematic review on CYP2C9, CYP2C19 and CYP2D6

    Pharmacogenetics of drug–drug interaction and drug–drug–gene interaction: a systematic review on CYP2C9, CYP2C19 and CYP2D6 de réir Muh. Akbar Bahar, Didik Setiawan, Eelko Hak, Bob Wilffert

    Foilsithe / Cruthaithe 2017
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  5. 5
    Pharmacogenetic differences between warfarin, acenocoumarol and phenprocoumon

    Pharmacogenetic differences between warfarin, acenocoumarol and phenprocoumon de réir J. R. B. J. Brouwers, Tom Schalekamp, Bob Wilffert, Maarten J. Beinema

    Foilsithe / Cruthaithe 2008
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  6. 6
    Clinical response to antipsychotic drug treatment: Association study of polymorphisms in six candidate genes

    Clinical response to antipsychotic drug treatment: Association study of polymorphisms in six candidate genes de réir Jelle Vehof, Huibert Burger, Bob Wilffert, Asmar Al Hadithy, Behrooz Z. Alizadeh, Harold Snieder

    Foilsithe / Cruthaithe 2012
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  7. 7
    Association between Adherence to Guideline-Recommended Preventive Medications and In-Hospital Mortality among Non-Reperfused ST-Elevation Myocardial Infarction Patients Admitted to a Tertiary Care Academic Center in a Developing Country

    Association between Adherence to Guideline-Recommended Preventive Medications and In-Hospital Mortality among Non-Reperfused ST-Elevation Myocardial Infarction Patients Admitted to... de réir Sylvi Irawati, Surya Dharma, Katja Taxis, Thắng Nguyễn, Nunung Nursyarofah, Bob Wilffert, Eelko Hak

    Foilsithe / Cruthaithe 2020
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  8. 8
    A simple dried blood spot method for therapeutic drug monitoring of the tricyclic antidepressants amitriptyline, nortriptyline, imipramine, clomipramine, and their active metabolites using LC-MS/MS

    A simple dried blood spot method for therapeutic drug monitoring of the tricyclic antidepressants amitriptyline, nortriptyline, imipramine, clomipramine, and their active metabolit... de réir E.J.J. Berm, J. Paardekooper, E. Brummel-Mulder, Eelko Hak, Bob Wilffert, Jan Gerard Maring

    Foilsithe / Cruthaithe 2014
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  9. 9
    The association between the <i>NAT2</i> genetic polymorphisms and risk of DILI during anti‐TB treatment: a systematic review and meta‐analysis

    The association between the <i>NAT2</i> genetic polymorphisms and risk of DILI during anti‐TB treatment: a systematic review and meta‐analysis de réir Min Zhang, Shuqiang Wang, Bob Wilffert, Rongsheng Tong, Dick van Soolingen, Susan van den Hof, Jan‐Willem C. Alffenaar

    Foilsithe / Cruthaithe 2018
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  10. 10
    Economic Evaluations of Pharmacogenetic and Pharmacogenomic Screening Tests: A Systematic Review. Second Update of the Literature

    Economic Evaluations of Pharmacogenetic and Pharmacogenomic Screening Tests: A Systematic Review. Second Update of the Literature de réir E.J.J. Berm, Margot de Looff, Bob Wilffert, Cornelis Boersma, Lieven Annemans, Stefan Vegter, Job F. M. van Boven, Maarten J. Postma

    Foilsithe / Cruthaithe 2016
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  11. 11
    Potential antimicrobial agents for the treatment of multidrug-resistant tuberculosis

    Potential antimicrobial agents for the treatment of multidrug-resistant tuberculosis de réir Noor Alsaad, Bob Wilffert, Richard van Altena, Wiel C.M. de Lange, Tjip S. van der Werf, Jos G.W. Kosterink, Jan‐Willem C. Alffenaar

    Foilsithe / Cruthaithe 2013
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  12. 12
    Remission of Type 2 Diabetes Mellitus in Patients After Different Types of Bariatric Surgery

    Remission of Type 2 Diabetes Mellitus in Patients After Different Types of Bariatric Surgery de réir Jan Peter Yska, Eric N. van Roon, Anthonius de Boer, Hubert G. M. Leufkens, Bob Wilffert, Loek J. M. de Heide, Frank de Vries, Arief Lalmohamed

    Foilsithe / Cruthaithe 2015
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  13. 13
    Current status and opportunities for therapeutic drug monitoring in the treatment of tuberculosis

    Current status and opportunities for therapeutic drug monitoring in the treatment of tuberculosis de réir Marlanka A. Zuur, Mathieu S. Bolhuis, Richard Anthony, Alice den Hertog, Tridia van der Laan, Bob Wilffert, Wiel de Lange, Dick van Soolingen, Jan‐Willem C. Alffenaar

    Foilsithe / Cruthaithe 2016
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  14. 14
    P-Glycoprotein-Mediated Drug Interactions in Pregnancy and Changes in the Risk of Congenital Anomalies: A Case-Reference Study

    P-Glycoprotein-Mediated Drug Interactions in Pregnancy and Changes in the Risk of Congenital Anomalies: A Case-Reference Study de réir Nur Aizati Athirah Daud, Jorieke E. H. Bergman, Marian K. Bakker, Hao Wang, Wilhelmina S. Kerstjens‐Frederikse, Hermien E. K. de Walle, Henk Groen, Jens H. J. Bos, Eelko Hak, Bob Wilffert

    Foilsithe / Cruthaithe 2015
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  15. 15
    Association Between BDNF Gene Variant Rs6265 and the Severity of Depression in Antidepressant Treatment-Free Depressed Patients

    Association Between BDNF Gene Variant Rs6265 and the Severity of Depression in Antidepressant Treatment-Free Depressed Patients de réir Innokentiy S. Losenkov, Nathaniël J. V. Mulder, Л. А. Левчук, N. Vyalova, A.J.M. Loonen, Fokko J. Bosker, Г. Г. Симуткин, Anastasiia S. Boiko, Н. А. Бохан, Bob Wilffert, Eelko Hak, Amand F. Schmidt, Svetlana А. Ivanova

    Foilsithe / Cruthaithe 2020
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  16. 16
    NMDA receptor genotypes associated with the vulnerability to develop dyskinesia

    NMDA receptor genotypes associated with the vulnerability to develop dyskinesia de réir Svetlana А. Ivanova, A.J.M. Loonen, Petros Pechlivanoglou, Maxim B. Freidin, A.F.Y. Al Hadithy, E.V. Rudikov, Irina Zhukova, Н. В. Говорин, В.А. Сорокина, Olga Fedorenko, В. М. Алифирова, A. Semke, J. R. B. J. Brouwers, Bob Wilffert

    Foilsithe / Cruthaithe 2012
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  17. 17
    Pharmacogenetic Information in Clinical Guidelines: The European Perspective

    Pharmacogenetic Information in Clinical Guidelines: The European Perspective de réir Jesse J. Swen, Marga Nijenhuis, Mandy van Rhenen, Nienke J. de Boer‐Veger, Anne‐Marie Buunk, Elisa J. F. Houwink, Hans Mulder, Gerard A. Rongen, Ron H. N. van Schaik, Jan van der Weide, Bob Wilffert, Vera H.M. Deneer, Henk‐Jan Guchelaar

    Foilsithe / Cruthaithe 2018
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  18. 18
    Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene–drug interaction between CYP2D6 and opioids (codeine, tramadol and oxycodone)

    Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene–drug interaction between CYP2D6 and opioids (codeine, tramadol and oxycodone) de réir Maja Matić, Marga Nijenhuis, Bianca Soree, Nienke J. de Boer‐Veger, Anne‐Marie Buunk, Elisa J. F. Houwink, Hans Mulder, Gerard A. Rongen, Jan van der Weide, Bob Wilffert, Jesse J. Swen, Henk‐Jan Guchelaar, Vera H.M. Deneer, Ron H. N. van Schaik

    Foilsithe / Cruthaithe 2021
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  19. 19
    Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2C19 and CYP2D6 and SSRIs

    Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2C19 and CYP2D6 and SSRIs de réir J. Brouwer, Marga Nijenhuis, Bianca Soree, Henk‐Jan Guchelaar, Jesse J. Swen, Ron H. N. van Schaik, Jan van der Weide, Gerard A. Rongen, Anne‐Marie Buunk, Nienke J. de Boer‐Veger, Elisa J. F. Houwink, Roos van Westrhenen, Bob Wilffert, Vera H.M. Deneer, Hans Mulder

    Foilsithe / Cruthaithe 2021
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  20. 20
    Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene–drug interaction of DPYD and fluoropyrimidines

    Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene–drug interaction of DPYD and fluoropyrimidines de réir Carin A.T.C. Lunenburg, Cathelijne H. van der Wouden, Marga Nijenhuis, Mandy H. Crommentuijn-van Rhenen, Nienke J. de Boer‐Veger, Anne M. Buunk, Elisa J. F. Houwink, Hans Mulder, Gerard A. Rongen, Ron H. N. van Schaik, Jan van der Weide, Bob Wilffert, Vera H.M. Deneer, Jesse J. Swen, Henk‐Jan Guchelaar

    Foilsithe / Cruthaithe 2019
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:

Uirlisí cuardaigh: